VACCELERATE_EU

VACCELERATE_EU is a leading clinical research network dedicated to the coordination and execution of COVID-19 vaccine trials. Comprising academic institutions across Europe, VACCELERATE_EU plays a crucial role in advancing vaccine development and ensuring public health readiness. With its primary address in Cologne, DE, VACCELERATE_EU serves as a central hub for stakeholders involved in COVID-19 vaccine development, including pharmaceutical companies, academic institutions, and European health authorities.

VACCELERATE_EU offers a comprehensive suite of expertise, services, and resources designed to expedite the development and authorization of innovative vaccines and vaccination strategies. By addressing critical research questions such as vaccine efficacy against virus variants and trials for diverse populations, VACCELERATE_EU is at the forefront of scientific advancement. The establishment of a European Volunteer Registry facilitates the efficient recruitment of trial participants, further accelerating the research process.

VACCELERATE_EU is committed to enhancing the capacity of clinical trial sites and laboratories through standardized methods and protocols, as well as providing comprehensive training and quality management. This ensures harmonized vaccine trials and contributes to the overall effectiveness of the network. We invite the management of VACCELERATE_EU to create a customized and exclusive company showcase and product listing on our platform, to present more company information.